Other languages AtriCure, Inc.

Equities

ATRC

US04963C2098

Delayed Nasdaq Other stock markets 03:55:21 2024-06-10 pm EDT			5-day change	1st Jan Change
21.8 ^USD	-2.77%		-2.77%	-38.92%

May. 14	Transcript : AtriCure, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:15 AM
May. 02	Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AtriCure, Inc. Provides Earnings Guidance for the Year 2024	May. 01
AtriCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01
AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	Apr. 18
AtriCure Insider Sold Shares Worth $307,510, According to a Recent SEC Filing	Mar. 07
Atricure, Inc. Appoints Shlomi Nachman as Director, Member of Each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee	Feb. 27
AtriCure Q4 Loss Widens, Revenue Rises; 2024 Guidance Set	Feb. 15
Atricure, Inc. Provides Earnings Guidance for 2024	Feb. 15
AtriCure, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15
AtriCure Reports Higher Preliminary Q4, 2023 Revenue; Issues 2024 Revenue Guidance; Shares Rise	Jan. 08
Atricure, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Provides Financial Guidance for the Year 2024	Jan. 08
AtriCure, Inc. Appoints Shlomi Nachman to its Board of Directors	Jan. 04
AtriCure's Q3 Adjusted Loss Narrows, Revenue Rises; Full-Year Guidance Adjusted	Nov. 01
AtriCure, Inc. Provides Revenue Guidance for the 2023	Nov. 01
AtriCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01
Insider Sell: Atricure	23-07-28
AtriCure Q2 Non-GAAP Loss Narrows as Sales Increase	23-07-25
Atricure, Inc. Provides Revenue Guidance for the Year 2023	23-07-25
AtriCure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25
Insider Sell: Atricure	23-05-30
Insider Sell: Atricure	23-05-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AtriCure, Inc.

Equities

ATRC

US04963C2098

Other languages

Filters